Home Blog Page 1140

Elliott Management Statement on Toyota Industries Corporation

Toyota Fudosan’s tender offer drastically undervalues the Company

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender

LONDON, Feb. 3, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant investment in Toyota Industries Corporation (“Toyota Industries” or the “Company”) and are the Company’s largest independent shareholder, today issued the following statement:

Elliott notes the non-binding statement issued today by an affiliate of Toyota Fudosan Co., Ltd. (“Toyota Fudosan”). Elliott maintains its position that the revised tender offer by Toyota Fudosan at ¥18,800 per share (the “Revised TOB”) very significantly undervalues Toyota Industries, as Elliott demonstrates in its public materials. Elliott continues to strongly disagree with Toyota Fudosan’s assertion that the Revised TOB price “reflects the intrinsic value of the Target Company“.

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender.

Elliott’s previously released public materials can be found at https://elliottletters.com

About Elliott

Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

Investor Contacts:

Okapi Partners LLC
New York: Pat McHugh
T:+1 212 297 0720
Toll Free: (877) 629-6357
London: Christian Jacques
T: +44 20 3031 6613
TICO@okapipartners.com

Media Contacts:

London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk

New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com

Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp

Hecto Financial Integrates with Circle Payments Network to Enable Stablecoin-Based Payments

SEOUL, South Korea, Feb. 3, 2026 /PRNewswire/ — Hecto Financial, a regulated financial services provider in South Korea, announced today its integration with Circle Payments Network (CPN). The integration provides Hecto Financial with access to a global settlement infrastructure for cross-border payments using regulated stablecoins such as USDC.

Hecto Financial Integrates with Circle Payments Network to Enable Stablecoin-Based Payments
Hecto Financial Integrates with Circle Payments Network to Enable Stablecoin-Based Payments

Moving forward, Hecto Financial plans to streamline overseas remittance and settlement procedures through CPN, in alignment with domestic regulatory standards in South Korea, to provide faster and more secure cross-border payment services to both domestic and international customers.

Operated by Circle Technology Services, LLC, an affiliate of Circle Internet Group, Inc. (NYSE: CRCL), CPN connects financial institutions, payment providers, and fintechs to facilitate programmable, always-on settlement using stablecoins such as USDC and EURC. The network is designed to unify traditional and blockchain-based payment systems while eliminating intermediaries and supporting real-time settlement.

Through CPN, Hecto Financial aims to enhance the speed, efficiency, and global reach of its cross-border payment services for enterprise clients and platform partners. Supported use cases include B2B payments, remittances, and treasury flows.

“As financial infrastructure evolves, we see an opportunity to offer clients new ways to move value quickly across borders in a compliant manner,” said Jong-won Choi, CEO of Hecto Financial. “In line with the global shift toward stablecoin-centered financial infrastructure, Hecto Financial aims to help establish a foundation for the KRW-based digital payment ecosystem to expand into global markets and contribute to enhancing the international standing of the Korean Won.”

“Hecto Financial’s integration with Circle Payments Network supports the delivery of near-instant cross-border payments across key global corridors,” said Irfan Ganchi, SVP of Product Management, Payments at Circle. “By connecting to CPN, Hecto enables programmable money movement that aligns with the demands of today’s digital economy.”

This integration builds on Hecto Financial’s participation in the October 2025 public testnet of Arc, Circle’s enterprise-grade layer-1 blockchain designed as the Economic Operating System (OS) for the internet, where it joined over 100 institutions in validating early infrastructure use cases.

About Hecto Financial

Hecto Financial (KOSDAQ: 234340) is a leading, regulated financial services provider in South Korea, offering a comprehensive suite of integrated payment solutions and financial infrastructure. The company specializes in virtual accounts, automated settlement systems, and innovative cross-border payment services. Leveraging its robust domestic network and advanced technological capabilities, Hecto Financial is at the forefront of modernizing financial services by bridging traditional banking systems with digital assets and blockchain-based settlement networks. The company is committed to delivering secure, compliant, and efficient financial tools for enterprise clients and platform partners globally.

About Circle Payments Network

Circle Technology Services, LLC (CTS) is the operator of Circle Payments Network (CPN) and offers products and services to financial institutions that participate in CPN to facilitate their CPN access and integration. CPN connects participating financial institutions around the world, with CTS serving as the technology service provider to participating financial institutions. While CTS does not hold funds or manage accounts on behalf of customers, we enable the global ecosystem of participating financial institutions to connect directly with each other, communicate securely, and settle directly with each other. CTS is not a party to transactions between participating financial institutions facilitated by CPN who use CPN to execute transactions at their own risk. Use of CPN is subject to the CPN Rules and the CPN Participation Agreement between CTS and a participating financial institution.

21 Asian Countries Among 93 Worldwide at Risk of Losing Nearly 23 Million More People by 2030

  • ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts in 93 countries, with 21 in Asia
  • New study published in The Lancet finds slashing global aid, particularly by US and European countries, will reverse decades of progress in fighting diseases

BANGKOK, Feb. 3, 2026 /PRNewswire/ — The Lancet Global Health published a new peer-reviewed study today by the Barcelona Institute for Global Health (ISGlobal), which warns that a precipitous drop in global aid could lead to 22.6 million additional deaths by 2030 across 93 low- and middle- income countries, including 5.4 million children under the age of five. With support from The Rockefeller Foundation, the analysis demonstrates that Sub-Saharan Africa, which accounts for 38 of the 93 countries analyzed, is particularly at risk, and with 21 of the countries in Asia, 12 in Latin America, 12 in the Middle East and North Africa, and 10 in Europe, including Ukraine, severe cuts to official development assistance (ODA) could be felt globally. ISGlobal’s research also reveals that over the course of 2002-2021, ODA helped reduce child mortality by 39%; prevent HIV/AIDS deaths by 70%, with a 56% reduction in deaths from both malaria and nutritional deficiencies; and increased additional global health outcomes in these 93 countries, which are home to 75% of the world’s population.

“These findings are a warning of the profound moral cost of the zero-sum approach many political leaders are taking—and they are an urgent call to action to all of us to prevent this human suffering,” said Dr. Rajiv J. Shah, President of The Rockefeller Foundation in a Statement on the Human Cost of Foreign Aid Cuts. “The question before humanity today is whether we will accept a global retreat from commitments to feed the hungry, cure the sick, and lift up the most vulnerable define the future or whether we will come together to build new models of cooperation worthy of the tens of millions of people who could lose their lives if we do not.”

In 2024 international aid fell for the first time in six years, and the United States, United Kingdom, France, and Germany significantly reduced their ODA contributions for the first time in nearly 30 years. These deep cuts, along with projected cuts in 2025 and 2026, sparked the need to understand what this could mean at the human level for communities all over the world.

“Our analyses show that development assistance is among the most effective global health interventions available. Over the past two decades, it has saved an extraordinary number of lives and strengthened fragile welfare states and healthcare systems. Withdrawing this support now would not only reverse hard-won progress, but would translate directly into millions of preventable adult and child deaths in the coming years. Budget decisions made today in donor countries will have irreversible consequences for millions of people for years to come,” said Davide Rasella, Coordinator of the study, ICREA Research Professor at ISGlobal and at the Brazilian Institute of Collective Health.

Millions More Lives at Risk:
As the world’s largest donors and other countries around the world continued to slash billions in assistance, the Organisation of Economic Cooperation and Development (OECD) is projecting that ODA could decline by 10%-18% from 2024 to 2025. In order to assess the realized impact of ODA in these countries and project what may happen if current aid cuts continue or worsen, ISGlobal – with support from The Rockefeller Foundation in association with its charitable offshoot, RF Catalytic Capital – examined 20 years of development data between 2002 and 2021 in 93 countries that are home to 6.3 billion people.  

“Asia’s scale means that when health systems fail, the human cost is immense, and in 21 countries across the region, decades of development gains are now at risk of being reversed,” said Deepali Khanna, Senior Vice President & Head of Asia, The Rockefeller Foundation. “Without sustained and smarter development assistance, hard-won progress against disease can disappear, health systems can weaken, and preventable loss of life can follow. These outcomes are not inevitable, but avoiding them requires country-led financing and resilient, self-reliant systems that can protect the most vulnerable and save lives.”

Peer reviewed and published by The Lancet Global Health, The Impact of Two Decades of Humanitarian and Development Assistance and the Projected Mortality Consequences of Current Defunding to 2030: Retrospective Evaluation and Forecasting Analysis, models two scenarios over the course of 2025-2030:

  1. Mild defunding scenario. With a 10.6% yearly reduction (corresponding to the average reduction of the last two years, 2024–2025), these cuts could result in 9.4 million preventable deaths, including 2.5 million children younger than five years.
  2. Severe defunding scenario. Based on $32 billion (15.1%) in ODA cuts from 2024 to 2025, with the funding cuts continuing and worsening through the end of this decade, this could cause 5.4 million children younger than age five years to die as part of more than 22.6 million additional deaths of all ages – Roughly equivalent to (1) the combined populations of greater Barcelona, Paris, and London; (2) more than the individual populations of Mexico City, Dhaka, Sao Paulo, Cairo, and Mumbai; (3) or the entire U.S. State of Florida perishing by 2030.

ISGlobal researchers applied a consistent methodological framework that integrates longitudinal panel data with validated country-level microsimulation models to quantify the health consequences of funding reductions across all OECD contributors. As result, the new study also demonstrates that higher global ODA levels in the 93 countries analyzed between 2002 and 2021 contributed to:

  • Decreasing all-cause mortality by 23%.
  • Declining child mortality by 39%.
  • Reducing deaths mortality rates from HIV/AIDS by 70%, nutritional deficiencies by 56%, malaria by 56%, diarrheal diseases by 55%, and neglected tropical diseases by 54%.
  • Strengthening health systems and supporting disease control and eradication efforts.
  • Improving preparedness for outbreaks and epidemics.

It also warns that at least three out of every four people on the planet live in countries where two decades of development gains could be reversed, where progress against diseases disappears, and where preventable loss of life could happen. The countries analyzed in this study include:

  • 21 countries in Asia:
    Afghanistan, Azerbaijan, Bangladesh, Cambodia, China, India, Indonesia, Kazakhstan, Kyrgyzstan, Laos, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Tajikistan, Thailand, Uzbekistan, and Vietnam.
  • 10 countries in Europe:
    Albania, Armenia, Belarus, Bosnia and Herzegovina, Georgia, North Macedonia, Moldova, Montenegro, Serbia, and Ukraine.
  • 12 countries in Latin America:
    Argentina, Bolivia, Brazil, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Paraguay, and Peru.
  • 12 countries in the Middle East and North Africa:
    Algeria, Djibouti, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Sudan, Tunisia, and Turkiye.
  • 38 countries in Sub-Saharan Africa:
    Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, South Africa, Tanzania, Togo, Uganda, Zambia, and Zimbabwe.

As a result of the severe realized and projected cuts to ODA, The Rockefeller Foundation is undertaking its mission-driven work around the world – with a focus on Sub-Saharan Africa – to identify country-led solutions to maximize every dollar of remaining aid and to stimulate new investments. This work, along with ISGlobal’s research, is supported by the Foundation’s Build the Shared Future Initiative, through which the 113-year-old philanthropic organization aims to inspire and inform global cooperation and international development work that matches the challenges of the 21st century. 

Researchers from ISGlobal – a Barcelona-based institution supported by the “la Caixa” Foundation, together with the Institute of Collective Health at the Federal University of Bahia (UFBA) in Brazil, the Mozambique-based Manhiça Health Research Centre (CISM), and the National Institute of Health (INS) – submitted this report to The Lancet Global Health on 18 November 2025.

It builds on an ISGlobal-led study published last year, which found that the dismantling of the U.S. Agency for International Development (USAID) alone could lead to over 14 million additional preventable deaths by 2030. Both analyses applied the same methodological framework, integrating longitudinal panel data with validated country-level microsimulation models—to quantify the health consequences of funding reductions. While the USAID study focused on a single donor, the new analysis encompasses all OECD contributors, providing a comprehensive assessment of global aid defunding on mortality.

For additional information and download a copy of ISGlobal’s latest study, please visit:
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(26)00008-2/fulltext.

About The Barcelona Institute for Global Health (ISGlobal)
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between the “la Caixa” Foundation, academic institutions and government bodies to contribute to the efforts undertaken by the international community to address the challenges in global health. ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University. Its working model is based on the generation of scientific knowledge through Research Programmes and Groups, and its translation through the areas of Education and Training and Analysis and Global Development. Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world. For more information, visit www.isglobal.org.

About The Rockefeller Foundation
Investing $30 billion over the last 113 years to promote the well-being of humanity, The Rockefeller Foundation is a pioneering philanthropy built on unlikely partnerships and innovative solutions that deliver measurable results for people in the United States and around the world. We leverage scientific breakthroughs, artificial intelligence, and new technologies to make big bets across energy, food, health, and finance, including with our charitable offshoot, RF Catalytic Capital (RFCC).  For more information, sign up for our newsletter at www.rockefellerfoundation.org/subscribe and follow us on X @RockefellerFdn, Instagram @rockefellerfdn, YouTube @RockefellerFdn, and LinkedIn @the-rockefeller-foundation.

ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency, precision, and surgical safety.

JENA, Germany and SHANGHAI, Feb. 3, 2026 /PRNewswire/ — ZEISS Medical Technology announced today that China’s National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high quality optical and digital visualization for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly approved microscopes supporting ophthalmic surgeries ensure more precise operations and greater surgical safety with enhanced resolution, RGB illumination and full compatibility with the latest generation of ZEISS’s cataract workflow.

ZEISS ARTEVO 750
ZEISS ARTEVO 750

“The introduction of ZEISS ARTEVO 750 and ARTEVO 850 microscopes powerfully demonstrates our commitment to ophthalmologists in China. We will leverage the power of innovation to contribute to the advancement of eye health in China and better serve Chinese surgeons and their patients,” says Martin Fischer, President & CEO of ZEISS Greater China.

The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS’s ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE). Combining advanced technology with established optical expertise, the ARTEVO 750 enables surgeons to finetune their surgical views in routine and complex procedures, including cataract & vitreoretinal surgery, corneal transplantation, and minimally invasive glaucoma surgery (MIGS). With enhanced resolution, elevated depth of field, intelligent RGB illumination and intraoperative OCT, the ZEISS ARTEVO 750 supports excellent usability and a seamless end-to-end workflow.

“The enhanced optical resolution of the ARTEVO 750 enables us to elevate our capabilities in performing delicate ophthalmic surgeries,” states Professor Chen Jili from Shanghai Jing’an District Shibei Hospital.

The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for multiple specialties in ophthalmology, setting the pace in digital visualization. It combines the proven benefits of a digital ophthalmic microscope with customizable 3D digital visualization, functional integration, excellent usability, and integration into a comprehensive medical ecosystem. Digital Color Assistant (DCA) enhances colors in the surgical image to accentuate anatomical details. Another advantage of digital visualization includes optimization of the depth of field up to 60%1 with Smart Depth of Field (DoF) function. A redesigned user interface for ZEISS CALLISTO eye centralizes all controls onto a single intuitive touchscreen. Digital integration into ZEISS ophthalmic workflows allows for seamless data transfer, with reference image matching directly on the 3D screen and a markerless toric IOL implantation that can be fully surgeon controlled.

Professor Xu Gezhi from the EENT Hospital of Fudan University explains, “The resolution of the ARTEVO 850 is truly excellent, and the clear visibility and reduced fatigue during the surgery make the experience very pleasant.”

The availability in China of the next generation of ZEISS ophthalmic microscopes, including the ZEISS ARTEVO 750 and ARTEVO 850, helps transform the surgical experience with superior optics and capabilities.

The ZEISS ARTEVO 850 will be showcased as part of ZEISS’s ophthalmic workflows in the ZEISS booth #5FG-J01 at the 41st Asia-Pacific Academy of Ophthalmology (APAO) conference in Hong Kong from February 5-8, 2026. For more information about ZEISS ophthalmic surgical microscopes, visit here.

1 Data on file. Compared to ZEISS ARTEVO 800.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals’ content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.

Contact for investors
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.med@zeiss.com

Contact for the press
Frank Smith
Head of Global Communications
Ophthalmology, Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: press.med@zeiss.com

www.zeiss.com/newsroom

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med

ZEISS ARTEVO 850
ZEISS ARTEVO 850

 

Australian Public Sector AI Adoption Ramping Up, Yet Progress Hampered by Fragmented Systems and Data

SYDNEY, Feb. 3, 2026 /PRNewswire/ — New research from Appian (Nasdaq: APPN) reveals AI adoption in the public sector has gained rapid traction, with 70% of public sector workers reporting AI is now integrated into their daily tasks, a significant jump from 58% just one year ago. This places the public sector close behind large private enterprises, which continue to lead the market with an 82% AI adoption rate, according to Australian Government figures.

Further indicating the Australian public sector is increasingly ready to leverage AI-driven automation, the Appian survey of 500 Australian public sector workers, found that 68% are confident in understanding the AI tools used in their roles. This compares to just 59% in 2024.

“AI has the potential to revolutionise public sector processes, connecting siloed systems and automating routine tasks,” said Luke Thomas, Area Vice President Asia Pacific and Japan at Appian. “It’s really encouraging to see public sector workers becoming increasingly engaged with AI technologies as part of their daily roles. This can free up valuable time for staff to focus on more meaningful work and engage more effectively with citizens.”

However, Thomas cautions that many organisations continue to fall into the trap of implementing AI as isolated add-ons, such as standalone chatbots or copilots. “This kind of fragmented AI adoption doesn’t deliver the widespread improvements in productivity or resilience that public sector leaders are looking for.”

Digital growth across the public sector

The Appian research shows continued acceleration of digital transformation across Australia’s public sector. A substantial 87% of public sector workers say their organisation has implemented new digital initiatives over the past five years.

These new digital tools appear to be having an increasingly positive impact on public sector workers, with 81% reporting that digital transformation projects have improved collaboration and communication within their department or agency (compared to 64% in 2024). In addition, 86% reported that digital transformation has made public services more accessible to citizens, up from just 63% in 2024.

“The public sector manages enormous volumes of information, and workers face constant pressure around data management, compliance and administration,” said Thomas. “It’s really positive to see continued investment in digital tools translating into real improvements for staff and making public services more accessible for citizens.”

Disconnected data still a challenge

Digital progress, including AI, is being undermined by one big challenge: worsening system and data fragmentation. Appian’s research found that 72% of public sector workers report struggling with separate, disconnected databases within their organisation, a sharp rise from 56% in 2024.

The downstream impact is clear, as 64% of staff acknowledge that these disconnected databases have reduced collaboration within their department or agency (up from 49% in 2024). Additionally, 53% of workers find themselves working with incomplete, inaccessible information due to data siloes.

“The rise in digital tools alongside growing system fragmentation shows that many public sector organisations are rolling out technology in isolation rather than integrating it in a way that streamlines processes and connects information,” Thomas said.

“As a result, AI is falling short, but it’s not because of the technology itself. It falls short when organisations layer new tools on top of disconnected data, legacy systems and manual handoffs — conditions that make it impossible for technology to deliver its full value.”

A path forward

For the Australian public sector to realise the full return on its digital and AI investments, departments will need to shift focus from individual tools to the broader organisational value these technologies can unlock. This means looking beyond isolated deployments and instead understanding which end-to-end processes are most critical to service delivery, workforce efficiency and citizen outcomes.

“We encourage organisations to start with their processes, not the technology,” Thomas said. “Identify where the bottlenecks, delays and pain points sit. Only then can you determine where AI and other new technologies will meaningfully improve the process and deliver lasting impact.”

Methodology:

Appian commissioned Zoho research to survey 500 Australian public sector workers in Q4 2025.

About Appian

Appian provides process automation. We automate complex processes in large enterprises and governments. Our platform is known for its unique reliability and scale. We’ve been automating processes for 25 years and understand enterprise operations like no one else. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian: LinkedIn, Youtube, Instagram, Facebook

Logo – https://laotiantimes.com/wp-content/uploads/2026/02/appian_caption_2700px_logo.jpg 

How Tineco Makes Everyday Living Feel Effortless

SEATTLE, Feb. 3, 2026 /PRNewswire/ — Tineco today shared its design-led vision for modern floor care, highlighting how thoughtful engineering and human-centered thinking continue to shape more intuitive, effortless cleaning experiences. The approach reflects a broader evolution in how floor care fits naturally into everyday living.


In today’s homes, innovation is no longer judged by how advanced it sounds, but by how seamlessly it integrates into daily life. For Tineco, smart living has never been about adding complexity. Instead, it begins with thoughtful design—designed to reduce effort, remove decision-making, and create cleaning experiences that simply feel right.

Across its product portfolio, Tineco has built a reputation not only for performance, but for a design philosophy rooted in real consumer behavior. Each design choice is guided by one principle: make everyday living feel effortless.

Intelligence that works quietly in the background

One of the most defining examples of this philosophy is Tineco’s iLoop smart sensor technology. Rather than asking users to adjust modes, settings, or power levels, iLoop continuously senses real-time conditions and automatically adapts key performance elements—such as water flow, suction power, and brush movement—based on actual cleaning needs.

This intelligent balance allows products to deliver optimal performance without unnecessary resource use. By adjusting only when needed, iLoop helps extend runtime, reduce water replacement frequency, and maintain consistent cleaning results from start to finish. More importantly, it removes the mental load from the user. The product makes the decisions, so users don’t have to.

Developed from a consumer-first perspective, iLoop has become a core design foundation across Tineco’s floor washers, vacuum cleaners, and carpet cleaning solutions—reflecting a brand belief that true intelligence should feel invisible, intuitive, and reassuring.

Designed around how people actually move

Effortless cleaning is not only about intelligence — it’s also about how a product feels in use. From the early S3 series, Tineco began redefining what a floor washer could be, and with each generation, the brand has continued to refine the physical interaction between user and machine through extensive user testing and long-term feedback.

Over time, Tineco re-engineered key structural elements, including repositioning water tanks from the front of the body to the rear and eventually integrating them closer to the top of the brush head. These changes were driven by real-world usage studies, aimed at improving balance, reducing wrist strain, and creating a more natural cleaning posture.

Building on this foundation, later generations introduced assisted movement technologies that respond to user motion, subtly supporting both forward and backward movement. This approach allows the product to glide smoothly with minimal effort, creating a lighter, more controlled experience—especially during extended cleaning sessions.

Rethinking everyday categories through design

Tineco’s design thinking also extends to reimagining product categories that have traditionally been associated with heavy, infrequent use. In carpet care, conventional cleaners are often bulky and physically demanding, leading many households to use them infrequently, despite the investment.

By rethinking weight distribution and integrating clean and dirty water into a single, top-mounted tank positioned closer to the ground, Tineco redesigned the carpet cleaning experience to feel more balanced and approachable. Combined with assisted movement that helps guide the product across carpets, this design reduces physical strain and encourages more frequent, practical use.

This reimagined approach to carpet care is exemplified by the Carpet One Cruiser, which was recognized by TIME as one of its Best Inventions of 2025—an acknowledgment of how thoughtful design can transform everyday categories and make powerful tools genuinely accessible.

When products belong naturally in the home

As a brand that has played a key role in shaping the modern floor washer category, Tineco also believes that performance should coexist with living spaces—not compete with them. Over time, consumer feedback revealed a shift in expectations: cleaning appliances were no longer meant to be hidden away, but to exist naturally within modern interiors.

Beginning with the S9 Series, Tineco elevated material quality, refined proportions, and simplified its visual language. The result is a new generation of floor washers designed to sit comfortably within living rooms or bedrooms, complementing different interior styles while reinforcing a sense of pride and trust in ownership.

Designing for life, not just cleaning

For Tineco, smart design is not about chasing features—it’s about understanding how people live, move, and feel in their homes. By combining intelligent sensing, ergonomic engineering, and refined aesthetics, the brand continues to shape cleaning experiences that feel intuitive, balanced, and quietly powerful.

When design works well, it doesn’t demand attention—it simply makes everyday life easier.

About Tineco

Tineco (“tin-co”) was founded in 1998 with its first product launch as a vacuum cleaner and, in 2019, pioneered the first-ever smart vacuum. Today, the brand has evolved into a global leader in intelligent appliances spanning floor care, kitchen, and personal care categories. With a growing user base of over 23 million households and availability in approximately 30 countries worldwide, Tineco remains committed to its brand vision of making life easier through smart technology and continuous innovation. For more information, visit au.tineco.com.

FiEE, Inc. Provides Select Preliminary Fourth Quarter and Full-Year 2025 Financial Results and Business Update

Strong revenue growth supported by growing customer base and SaaS Solution Business

Expected to achieve a positive Net Income highlighting a successful transformation

HONG KONG, Feb. 3, 2026 /PRNewswire/ — FiEE, Inc. (NASDAQ:FIEE) (“FiEE,” the “Company,” “we,” “our,” or similar terms), a technology company integrating IoT, connectivity, and AI to redefine brand management solutions in the digital era, today provided an update on its business and select preliminary financial results for the fourth quarter and full year ended December 31, 2025. These include the following select preliminary financial results and updates:

Full Fiscal Year 2025 Select Preliminary Estimated Financial Results:

  • Net Sales of approximately $6 million
  • Gross profit of approximately $5 million
  • Net Income of approximately $1 million

Fourth Quarter 2025 Select Preliminary Estimated Financial Results:

  • Net Sales of approximately $4 million
  • Gross profit of approximately $3 million
  • Net Income of approximately $2 million

Rafael Li, Chief Executive Officer and President of FiEE, commented, “We are pleased with our strong fourth quarter 2025 performance, along with a full-year growth across both sales and profit.  Supported by our strategic transformation towards SaaS solutions, our net sales recorded an increase of 870.8% year-over-year. We also showed improved profitability, with gross profit increasing 2,506.1% year-on-year and Net Income achieving a turnaround to approximately $1 million. Looking ahead, we plan to remain committed to investing in R&D to enhance customer experience and deliver greater brand value across the digital content landscape. We look forward to sharing more details with you as we continue to execute over the coming year ahead.”

The preliminary financial results are unaudited, have not been reviewed by the Company’s independent registered public accountants, and remain subject to the completion of normal year-end accounting procedures and adjustments and are therefore subject to change. The Company expects to release final financial and operating results for the fiscal fourth quarter and fiscal year ended December 31, 2025 during March 2026.

About FiEE, Inc.

FiEE, Inc. (NASDAQ:FIEE), formerly Minim, Inc., was founded in 1977. The Company has a historical track record of delivering comprehensive WiFi/Software as a Service platform in the market. After years of development, FiEE made the strategic decision to transition to a Software First Model in 2024 to expand its technology portfolio and revenue streams. In 2025, FiEE rebranded itself as a technology company leveraging its expertise in IoT, connectivity, and AI to explore new business prospects and extend its global footprint.

FiEE’s services are structured into four key categories: Cloud-Managed Connectivity (WiFi) Platform, IoT Hardware Sales & Licensing, SAAS Solutions, and Professional To-C and To-B Services & Support. Notably, FiEE has introduced its innovative Software as a Service solutions, which integrates its AI and data analytics capabilities into content creation and brand management. This initiative has led to the nurturing of a robust pool of KOLs on major social media platforms worldwide, assisting them in developing, managing, and optimizing their digital presence across global platforms. FiEE’s services include customized graphics and posts, short videos, and editorial calendars tailored to align with brand objectives.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995. Forward-looking statements, written, oral or otherwise made, represent the Company’s expectation or belief concerning future events. Without limiting the foregoing, the words “believes,” “expects,” “may,” “might,” “will,” “should,” “seeks,” “intends,” “plans,” “strives,” “goal,” “estimates,” “forecasts,” “projects” or “anticipates” or the negative of these terms and similar expressions are intended to identify forward-looking statements. Forward-looking statements included in this press release may include, among others, statements relating to (i) the future financial position and results of operations of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our commitment to investing in R&D and ability to deliver brand value, and (iv) the timing of our release of final financial and operating results for the fiscal fourth quarter and fiscal year ended December 31, 2025.

By nature, forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statement. In addition, there may be other factors of which we are presently unaware or that we currently deem immaterial that could cause our actual results to be materially different from the results referenced in the forward-looking statements. All forward-looking statements contained in this press release are qualified in their entirety by this cautionary statement. Although we believe that our plans, intentions and expectations are reasonable, we may not achieve our plans, intentions or expectations. Forward-looking statements are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements, which speak only as of the date hereof. See “Risk Factors” and “Special Note Regarding Forward-Looking Statements” included in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including the Company’s most recent annual report on Form 10-K and other risk factors described from time to time in subsequent quarterly reports on Form 10-Q, or other subsequent filings with the SEC. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

For investor and media inquiries, please contact:
Email: fiee@dlkadvisory.com

Miroma Project Factory Builds Smart Recovery Companion to Support Life After Brain Injury

SYDNEY, Feb. 3, 2026 /PRNewswire/ — Miroma Project Factory (MPF) is proud to announce its appointment by Griffith University to co-develop a smart device app designed to support individuals returning home after acquired brain injury (ABI). The project – known as ROBIN: Return Home After Brain Injury – delivers a compassionate, co-designed, and clinically informed digital prototype that supports both patients and care teams through one of the most complex transitions in health: the shift from hospital to home.

ROBIN, a smart recovery companion co-created by Miroma Project Factory and Griffith University, bridges the critical transition from rehabilitation to home life.
ROBIN, a smart recovery companion co-created by Miroma Project Factory and Griffith University, bridges the critical transition from rehabilitation to home life.

Despite the efforts of rehabilitation services, many people with ABI continue to face unexpected challenges once discharged. Resourcing pressures, fragmented communication, and the overwhelming nature of recovery mean that critical supports often fall away just when patients need them most. That’s where ROBIN steps in.

A Digital Bridge Between Hospital and Home

Built in partnership with the research team from Griffith University and The Hopkins Centre, ROBIN is an AI-enhanced proof-of-concept app that allows people with ABI to track their therapy journey, set meaningful recovery goals, document their experiences, and access support resources – entirely on their own terms. With profile customisation, media-based journaling, and a visual dashboard of progress, it helps users take ownership of their recovery while staying connected to their care network.

The app was developed through a co-design approach involving survivors of brain injury, carers, and rehabilitation clinicians to ensure it responds to the real needs and realities of recovery. Each feature – whether it’s recording a milestone or mapping life goals – is purpose-built to foster self-awareness, reflection, and a shared understanding of what comes next.

“This is about giving people more than just a discharge date. It is about giving them structure, clarity and dignity at a time when those things can feel out of reach. This is at the heart of what Miroma Project Factory does best. Kat Robinson CEO MPF

A Launchpad for Innovation in Brain Injury Care

Though simple in design, the ROBIN app represents a strategic leap forward in ABI care. As a minimum viable product, it offers a clear and scalable starting point for broader innovation, including future integration with Android devices, real-time data sharing, and wider clinical trials. Early stakeholder feedback confirms its value not just as a patient companion, but as a potential tool for enhancing care coordination and visibility across multidisciplinary teams.

MPF’s involvement in the project extended beyond UX and technical development. The team worked closely with Griffith University to align the prototype with future research and funding goals – ensuring that ROBIN can evolve into a full-scale digital health intervention, capable of supporting grant applications and informing policy conversations.

About ROBIN

ROBIN (Return Home After Brain Injury) is a smart device app developed by Griffith University in collaboration with Miroma Project Factory. Created as a MVP (minimum viable product) for research and clinical validation, the app is designed to support individuals transitioning from inpatient rehabilitation to home after an acquired brain injury. ROBIN helps users track progress, set goals, document recovery, and access critical resources in a secure, user-friendly environment.

About Miroma Project Factory (MPF)

MPF is a multi-award-winning digital strategy and product studio that delivers innovative digital solutions across web, platforms, and systems. Specialising in purposeful technology, MPF works at the intersection of strategy, design, and engineering to create impactful digital products for organisations ready to lead. With deep expertise in healthcare, MPF helps clients scale responsibly, communicate clearly, and connect meaningfully with their audiences. For more information, visit www.theprojectfactory.com.

For media enquiries, interviews or partnership opportunities, please contact:
Miroma Project Factory
info@theprojectfactory.com